BL22 Immunotoxin
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for BL22 Immunotoxin, covering 2007-12-28 to 2015-04-28. Get the full timeline:
Most recent: Clinical Trial Update: BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 1]